## QLYS: Qualys, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -0.1% below STRENGTH zone (4.0-10.0%); PEG 4.10 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (51% of avg), momentum weakening (-2.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($134.26)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.00M) |
| Sells | 14 ($3.44M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 52.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Blackrock Inc.: 15.3% (-2.6%)
- Vanguard Group Inc: 12.3% (+2.9%)
- State Street Corpora: 3.9% (-1.6%)
- Geode Capital Manage: 3.4% (+0.3%)
- Boston Trust Walden : 3.2% (+0.7%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.8% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $3.4M in recent transactions.
3. Valuation stretched: PEG 4.1x requires aggressive growth execution.
4. Elevated short interest (13.3%): bears positioning against stock.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 4.10 signals overvaluation risk, limited margin of safety. Forward P/E 19.4x stretched relative to 6% growth. Quality metrics strong (ROE 39%, ROA 14%, margin 29%). Insider selling cluster ($3.4M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.5B |
| Beta | 0.55 |
| 52W Range | $112.61 - $155.47 |
| Short Interest | 13.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.10 |
| Forward P/E | 19.4 |
| Current P/E | 20.5 |
| YoY Growth | 5.7% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 2.7% to -0.1% (-2.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.2pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.6%) - potential reversal signal. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57. Volume at 51% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.15% (CS: 48) | Neutral |
| RSI_14 | 57.0 | Neutral |
| MACD Histogram | -0.40 | Bearish |
| vs SMA20 | 1.009x | Above |
| vs SMA50 | 1.064x | Above |
| vs SMA200 | 1.071x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $143.16
- **Stop Loss:** $134.26 (6.2% risk)
- **Target:** $152.06 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 134
- **Position Value:** $19,183.44
- **Portfolio %:** 19.18%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

### Earnings

**Next:** 2026-02-05 (Est: $1.78)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.56 | $1.86 | +19.2% |
| 2025Q2 | $1.48 | $1.68 | +13.3% |
| 2025Q1 | $1.47 | $1.67 | +13.8% |
| 2024Q4 | $1.37 | $1.60 | +17.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*